Ladostigil
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Ladostigil, covering 2017-06-15 to 2020-07-30. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Efficacy Study of Ladostigil in Mild to Moderate Probable Alzheimer's Disease [Phase 2]